Natriuretic peptides in assessment of left-ventricular dysfunction

References

• de Bold A. Heart atria granularity: effects of changes in water-electrolyte balance. Proc Soc Exp Biol Med 1979; 161: 508–511
   PubMed Web of Science ®Google Scholar
• de Bold A J, Borenstein H B, Veress A T, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Levin E R, Gardner D G, Samson W K. Natriuretic Peptides (review). New Engl J Med 1998; 339: 321–328
   PubMed Web of Science ®Google Scholar
• Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78–81
   PubMed Web of Science ®Google Scholar
• Stingo A J, Clavell A L, Aarhus L L, Burnett J C. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 1992; 262: H308–H312
   PubMed Web of Science ®Google Scholar
• Lopez M J, Wong S K, Kishinoto I, et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 1995; 378: 65–68
   PubMed Web of Science ®Google Scholar
• Saito Y, Nakao K, Arai H, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 1989; 83: 298–305
   PubMed Web of Science ®Google Scholar
• Wei C M, Kao P C, Lin J T, Heublein D M, Schaff H V, Burnett J C. Circulating beta-atrial natriuretic factor in congenstive heart failure in humans. Circulation 1993; 88: 1016–20
   PubMed Web of Science ®Google Scholar
• Hunt P J, Richards A M, Nicholls M G, Yandle T G, Doughty R N, Espiner E A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol 1997; 47: 287–296
   PubMed Web of Science ®Google Scholar
• Puschendorf B, Mair J. Cardiac diseases. Clinical Laboratory Diagnostics - Use and Assessment of Clinical Laboratory Results, L Thomas. TH Books, FrankfurtGermany 1998; 101–119
   Google Scholar
• Hall C, Aaaberge L, Stokke O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for ist use as a biochemical marker of atrial pressure in clinical routine. Circulation 1995; 91: 911
   PubMed Web of Science ®Google Scholar
• Murdoch D R, Byrne J, Morton J J, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997; 78: 594–597
   PubMed Web of Science ®Google Scholar
• Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996; 76: 129–136
   PubMed Web of Science ®Google Scholar
• Lerman A, Gibbons R J, Rodeheffer R J, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993; 341: 1105–1109
   PubMed Web of Science ®Google Scholar
• Cowie M R, Struthers A D, Wood D A, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1347–1351
   Web of Science ®Google Scholar
• McDonagh T A, Robb S D, Murdoch D R, et al. Biochemical detection of left-ventricular dysfunction. Lancet 1998; 351: 9–13
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Burnett J C, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988–994
   PubMed Web of Science ®Google Scholar
• Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure - Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509–516
   PubMed Web of Science ®Google Scholar
• Rouleau J L, Packer M, Moye L, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994; 24: 583–591
   PubMed Web of Science ®Google Scholar
• Richards A M, Nicholls M G, Yandle T G, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921–1929
   PubMed Web of Science ®Google Scholar
• Dickstein K. Natriuretic peptides in detection of heart failure (editorial). Lancet 1998; 351: 4
   PubMed Web of Science ®Google Scholar